Exact Mass: 451.1966

Exact Mass Matches: 451.1966

Found 84 metabolites which its exact mass value is equals to given mass value 451.1966, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Piscerythramine

4-Amino-5,7,3-trihydroxy-5-methoxy-2,6-diprenylisoflavone

C26H29NO6 (451.1995)


A hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3, prenyl groups at positions 2 and 6, a methoxy group at position 5 and an amino group at position 4.

   

tetrahydrogeranylgeranyl-PP

3,7,11,15-Tetramethylhexadeca-2,14-dien-1-yl (phosphonatooxy)phosphonic acid

C20H37O7P2 (451.2014)


Tetrahydrogeranylgeranyl-pp is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Tetrahydrogeranylgeranyl-pp can be found in a number of food items such as muskmelon, wax gourd, deerberry, and pineapple, which makes tetrahydrogeranylgeranyl-pp a potential biomarker for the consumption of these food products.

   

Xylogranatin H

Xylogranatin H

C26H29NO6 (451.1995)


   

Dapholdhamine D

Dapholdhamine D

C26H29NO6 (451.1995)


   

Isopiscerythramine

4-Amino-5,7,3-trihydroxy-5-methoxy-8,2-diprenylisoflavone

C26H29NO6 (451.1995)


   

O-Methylsakerinol A

O-Methylsakerinol A

C23H33NO6S (451.2028)


   

dysidine

dysidine

C23H33NO6S (451.2028)


A sesquiterpenoid isolated from the sponge Dysidea sp. that is 5-amino-2-hydroxy-3-methyl-1,4-benzoquinone in which one of the hydrogens of the methyl group is replaced by a 1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-2-yl group and one of the hydrogens attached to the nitrogen is replaced by a 2-sulfoethyl group. Dysidine selectively inhibits human synovial phospholipase A2 (EC 3.1.1.4) with an IC50 = 2.0 muM.

   

(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-3-methoxyphenethyl amide|O-methylsakerinol A

(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-3-methoxyphenethyl amide|O-methylsakerinol A

C23H33NO6S (451.2028)


   

SCHEMBL21397092

SCHEMBL21397092

C23H33NO6S (451.2028)


   

9beta,2-dihydroxy-4,5-dimethoxy-lythran-12-one|9beta-hydroxyvertine

9beta,2-dihydroxy-4,5-dimethoxy-lythran-12-one|9beta-hydroxyvertine

C26H29NO6 (451.1995)


   

Nakijiquinone R

Nakijiquinone R

C23H33NO6S (451.2028)


   

Ala Cys Lys Met

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923)


   

Ala Cys Met Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Ala Lys Cys Met

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923)


   

Ala Lys Met Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Ala Met Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Ala Met Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Ala Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Ala Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Cys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]-3-methylbutanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Cys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Lys Ala Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Lys Cys Val

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Lys Met Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Lys Val Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Met Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Met Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]hexanamido]propanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Val Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Cys Val Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]hexanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Ala Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Ala Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Cys Ala Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Cys Cys Val

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Cys Met Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Cys Val Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Met Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Met Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanoic acid

C17H33N5O5S2 (451.1923)


   

Lys Val Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Met Ala Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Met Ala Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]hexanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Met Cys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Met Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]hexanamido]propanoic acid

C17H33N5O5S2 (451.1923)


   

Met Lys Ala Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]propanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Met Lys Cys Ala

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-sulfanylpropanamido]propanoic acid

C17H33N5O5S2 (451.1923)


   

Val Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C17H33N5O5S2 (451.1923)


   

Val Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   

Val Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H33N5O5S2 (451.1923)


   
   

Fmoc-glu(ochx)-oh

Fmoc-glu(ochx)-oh

C26H29NO6 (451.1995)


   

AZ 628

3-(2-Cyanopropan-2-yl)-N-(4-methyl-3-((3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)phenyl)benzamide

C27H25N5O2 (451.2008)


AZ 628 is a pan-Raf kinase inhibitor with IC50s of 105, 34 and 29 nM for B-Raf, B-RafV600E, and c-Raf-1, respectively.

   

Tetrazolast meglumine [usan]

Tetrazolast meglumine [usan]

C17H25N9O6 (451.1928)


   

(1r)-1-[(4-{[(6,7-Dihydro[1,4]dioxino[2,3-C]pyridazin-3-Yl)methyl]amino}piperidin-1-Yl)methyl]-9-Fluoro-1,2-Dihydro-4h-Pyrrolo[3,2,1-Ij]quinolin-4-One

(1r)-1-[(4-{[(6,7-Dihydro[1,4]dioxino[2,3-C]pyridazin-3-Yl)methyl]amino}piperidin-1-Yl)methyl]-9-Fluoro-1,2-Dihydro-4h-Pyrrolo[3,2,1-Ij]quinolin-4-One

C24H26FN5O3 (451.202)


   

Homofenazine

Homofenazine

C23H28F3N3OS (451.1905)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

2-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]ethanesulfonic acid

2-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]ethanesulfonic acid

C23H33NO6S (451.2028)


   

tetrahydrogeranylgeranyl-PP

tetrahydrogeranylgeranyl-PP

C20H37O7P2-3 (451.2014)


   

[oxido-[(2E)-3,7,11,15-tetramethylhexadeca-2,14-dienoxy]phosphoryl] phosphate

[oxido-[(2E)-3,7,11,15-tetramethylhexadeca-2,14-dienoxy]phosphoryl] phosphate

C20H37O7P2-3 (451.2014)


   

N-[[2-(diethylamino)ethylamino]-sulfanylidenemethyl]-3-(4-methoxyphenyl)-1-phenyl-4-pyrazolecarboxamide

N-[[2-(diethylamino)ethylamino]-sulfanylidenemethyl]-3-(4-methoxyphenyl)-1-phenyl-4-pyrazolecarboxamide

C24H29N5O2S (451.2042)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide

C20H29N5O5S (451.1889)


   

(5Z)-5-[(1-Benzyl-3,4-dihydro-2H-quinolin-6-yl)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

(5Z)-5-[(1-Benzyl-3,4-dihydro-2H-quinolin-6-yl)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

C28H25N3O3 (451.1896)


   
   

AZ304

AZ304

C27H25N5O2 (451.2008)


AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity[1].

   

9,20-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one

9,20-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one

C26H29NO6 (451.1995)


   

methyl (2s,3s,5s,6r,10s)-5-hydroxy-2,6-dimethyl-21-oxo-3-(2-oxopropyl)-14-oxa-8-azahexacyclo[11.6.1.1⁵,¹⁹.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-1(19),13(20),15,17-tetraene-18-carboxylate

methyl (2s,3s,5s,6r,10s)-5-hydroxy-2,6-dimethyl-21-oxo-3-(2-oxopropyl)-14-oxa-8-azahexacyclo[11.6.1.1⁵,¹⁹.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-1(19),13(20),15,17-tetraene-18-carboxylate

C26H29NO6 (451.1995)


   

n-(2-{4-[(8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]-3-methoxyphenyl}ethyl)-3-methanesulfonylprop-2-enimidic acid

n-(2-{4-[(8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]-3-methoxyphenyl}ethyl)-3-methanesulfonylprop-2-enimidic acid

C23H33NO6S (451.2028)


   

(2s,4r)-2-hydroxy-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one

(2s,4r)-2-hydroxy-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one

C26H29NO6 (451.1995)


   

3-[4-amino-3-hydroxy-5-methoxy-2-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chromen-4-one

3-[4-amino-3-hydroxy-5-methoxy-2-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chromen-4-one

C26H29NO6 (451.1995)


   

(1s,13z,17r,19s,20r)-9,20-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one

(1s,13z,17r,19s,20r)-9,20-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one

C26H29NO6 (451.1995)


   

(2e)-n-[2-(4-{[(2e,6e)-8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}-3-methoxyphenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

(2e)-n-[2-(4-{[(2e,6e)-8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}-3-methoxyphenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

C23H33NO6S (451.2028)


   

2-[(5-{[(1r,2r,4as,8as)-1,2,4a,5-tetramethyl-1,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl}-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl)amino]ethanesulfonic acid

2-[(5-{[(1r,2r,4as,8as)-1,2,4a,5-tetramethyl-1,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl}-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl)amino]ethanesulfonic acid

C23H33NO6S (451.2028)


   

18-(furan-3-yl)-10-hydroxy-4,9,9,19-tetramethyl-5,17-dioxa-2-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,11-triene-6,16-dione

18-(furan-3-yl)-10-hydroxy-4,9,9,19-tetramethyl-5,17-dioxa-2-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,11-triene-6,16-dione

C26H29NO6 (451.1995)


   

methyl (2s,5s,6r,10s)-5-hydroxy-2,6-dimethyl-21-oxo-3-(2-oxopropyl)-14-oxa-8-azahexacyclo[11.6.1.1⁵,¹⁹.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-1(19),13(20),15,17-tetraene-18-carboxylate

methyl (2s,5s,6r,10s)-5-hydroxy-2,6-dimethyl-21-oxo-3-(2-oxopropyl)-14-oxa-8-azahexacyclo[11.6.1.1⁵,¹⁹.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-1(19),13(20),15,17-tetraene-18-carboxylate

C26H29NO6 (451.1995)


   

2-({5-[(2,4,8,8a-tetramethyl-1,3,4,4a,5,6-hexahydronaphthalen-2-yl)methyl]-4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)ethanesulfonic acid

2-({5-[(2,4,8,8a-tetramethyl-1,3,4,4a,5,6-hexahydronaphthalen-2-yl)methyl]-4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)ethanesulfonic acid

C23H33NO6S (451.2028)


   

(4s,8s,10r,14s,18r,19r)-18-(furan-3-yl)-10-hydroxy-4,9,9,19-tetramethyl-5,17-dioxa-2-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,11-triene-6,16-dione

(4s,8s,10r,14s,18r,19r)-18-(furan-3-yl)-10-hydroxy-4,9,9,19-tetramethyl-5,17-dioxa-2-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,11-triene-6,16-dione

C26H29NO6 (451.1995)


   

2-[(5-{[(2r,4s,4as,8as)-2,4,8,8a-tetramethyl-1,3,4,4a,5,6-hexahydronaphthalen-2-yl]methyl}-4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]ethanesulfonic acid

2-[(5-{[(2r,4s,4as,8as)-2,4,8,8a-tetramethyl-1,3,4,4a,5,6-hexahydronaphthalen-2-yl]methyl}-4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]ethanesulfonic acid

C23H33NO6S (451.2028)